CMG Pharmaceutical Co. Ltd (058820) — Net Asset Quality Index
CMG Pharmaceutical Co. Ltd (058820) has a Net Asset Quality Index of 65.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩305.96 Billion minus total liabilities of ₩104.41 Billion yields net assets of ₩201.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can CMG Pharmaceutical Co. Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
CMG Pharmaceutical Co. Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how CMG Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 65.9%, representing net assets of ₩201.55 Billion against total assets of ₩305.96 Billion KRW. Explore CMG Pharmaceutical Co. Ltd (058820) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for CMG Pharmaceutical Co. Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for CMG Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 058820 company net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 65.9% | ₩201.55 Billion | ₩305.96 Billion | ₩104.41 Billion | ▲ +3.4 pp |
| 2024 | 62.5% | ₩189.54 Billion | ₩303.44 Billion | ₩113.89 Billion | ▼ -16.1 pp |
| 2023 | 78.6% | ₩190.23 Billion | ₩242.10 Billion | ₩51.87 Billion | ▼ -8.1 pp |
| 2022 | 86.7% | ₩184.95 Billion | ₩213.26 Billion | ₩28.31 Billion | ▼ -6.0 pp |
| 2021 | 92.7% | ₩184.70 Billion | ₩199.17 Billion | ₩14.47 Billion | ▲ +0.0 pp |
| 2020 | 92.7% | ₩181.13 Billion | ₩195.36 Billion | ₩14.22 Billion | ▼ -1.0 pp |
| 2019 | 93.7% | ₩180.16 Billion | ₩192.24 Billion | ₩12.08 Billion | ▲ +2.8 pp |
| 2018 | 90.9% | ₩103.98 Billion | ₩114.38 Billion | ₩10.40 Billion | ▲ +1.5 pp |
| 2017 | 89.4% | ₩97.94 Billion | ₩109.57 Billion | ₩11.62 Billion | ▼ -1.7 pp |
| 2016 | 91.1% | ₩101.11 Billion | ₩110.98 Billion | ₩9.87 Billion | ▲ +8.3 pp |
| 2015 | 82.8% | ₩46.81 Billion | ₩56.53 Billion | ₩9.73 Billion | ▼ -1.6 pp |
| 2014 | 84.4% | ₩49.00 Billion | ₩58.07 Billion | ₩9.07 Billion | ▼ -3.2 pp |
| 2013 | 87.6% | ₩49.00 Billion | ₩55.91 Billion | ₩6.92 Billion | ▲ +32.3 pp |
| 2012 | 55.3% | ₩31.59 Billion | ₩57.11 Billion | ₩25.52 Billion | ▼ -10.7 pp |
| 2011 | 66.0% | ₩18.03 Billion | ₩27.31 Billion | ₩9.27 Billion | — |